Singapore markets open in 7 hours 46 minutes

Straits Times Index
3,338.94
-9.93(-0.30%)
S&P 500
5,271.44
-11.96(-0.23%)
Dow
38,579.34
+8.31(+0.02%)
Nasdaq
16,792.60
-36.07(-0.21%)
Bitcoin USD
70,568.48
+1,730.27(+2.51%)
CMC Crypto 200
1,476.91
+29.75(+2.06%)

Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY

Add to watchlist

33.22

+1.18

(+3.68%)

At close: 03:04PM CST

Loading interactive chart…

Reuters
Merck discontinues some cancer drug development with China's Sichuan Kelun
Chinese drugmaker Sichuan Kelun Pharmaceutical Co said on Monday that Merck & Co Inc was abandoning the joint development of two candidate cancer drugs which have yet to start clinical trials. Representatives for Merck did not immediately respond to a Reuters request for comment. The move comes days after Merck said it would pay Daiichi Sankyo $5.5 billion to jointly develop three of its candidate cancer drugs in a deal that could be worth up to $22 billion for the Japanese firm.